Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Späh

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The British Journal of Dermatology|August 21, 2008
Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approachF Späh
Cardiovascular Research|January 1, 1986
Bioelectrical and mechanical effects of tiapamil (Ro 11-1781) on isolated guinea pig myocardiumF Späh
Journal of Cardiovascular Pharmacology|January 1, 1984
Forskolin, a new positive inotropic agent, and its influence on myocardial electrogenic cation movementsF Späh
Journal of Cardiovascular Pharmacology|November 1, 1984
Asocainol, a new antiarrhythmic drug with natrium- and calcium-antagonistic effects on ventricular myocardiumF Späh
Psychological Reports|February 12, 2026
Person-Environment Fit, Emotional Exhaustion, and Depression: The Mediating Role of Workplace BelongingMarieke Späh, Marie Andela
Blood Pressure. Supplement|January 1, 1995
Potential beneficial effects of urapidil in primary and secondary prevention of strokeF Späh, S O Walsemann
Journal of Cardiovascular Pharmacology|January 1, 1988
Treatment of hypertensive urgencies and emergencies with nitrendipine, nifedipine, and clonidine: effect on blood pressure and heart rateF Späh, K D Grosser
Journal of Cardiovascular Pharmacology|April 1, 1994
Effects of single intravenous administration of urapidil and diltiazem in patients with nonfixed pulmonary hypertension secondary to chronic obstructive lung diseaseF Späh, R Kottman, U Schmidt
Expert Opinion on Therapeutic Targets|November 28, 2023
The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potentialJulia Steinmetz-Späh, Per-Johan Jakobsson
Herz|September 19, 2000
[The symptomatic patient with pathologic coronary angiogram. "evidence-based" or "best-evidence medicine" in the interventional cardiology]O Volk, F Späh, H G Klues
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The British Journal of Dermatology|August 21, 2008
Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approachF Späh
Cardiovascular Research|January 1, 1986
Bioelectrical and mechanical effects of tiapamil (Ro 11-1781) on isolated guinea pig myocardiumF Späh
Journal of Cardiovascular Pharmacology|January 1, 1984
Forskolin, a new positive inotropic agent, and its influence on myocardial electrogenic cation movementsF Späh
Journal of Cardiovascular Pharmacology|November 1, 1984
Asocainol, a new antiarrhythmic drug with natrium- and calcium-antagonistic effects on ventricular myocardiumF Späh
Psychological Reports|February 12, 2026
Person-Environment Fit, Emotional Exhaustion, and Depression: The Mediating Role of Workplace BelongingMarieke Späh, Marie Andela
Blood Pressure. Supplement|January 1, 1995
Potential beneficial effects of urapidil in primary and secondary prevention of strokeF Späh, S O Walsemann
Journal of Cardiovascular Pharmacology|January 1, 1988
Treatment of hypertensive urgencies and emergencies with nitrendipine, nifedipine, and clonidine: effect on blood pressure and heart rateF Späh, K D Grosser
Journal of Cardiovascular Pharmacology|April 1, 1994
Effects of single intravenous administration of urapidil and diltiazem in patients with nonfixed pulmonary hypertension secondary to chronic obstructive lung diseaseF Späh, R Kottman, U Schmidt
Expert Opinion on Therapeutic Targets|November 28, 2023
The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potentialJulia Steinmetz-Späh, Per-Johan Jakobsson
Herz|September 19, 2000
[The symptomatic patient with pathologic coronary angiogram. "evidence-based" or "best-evidence medicine" in the interventional cardiology]O Volk, F Späh, H G Klues
Pageof 5